Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells.
暂无分享,去创建一个
Carmela Fimognari | Davide Sciuscio | P. Hrelia | C. Fimognari | M. Lenzi | Davide Sciuscio | G. Cantelli-forti | Monia Lenzi | Giorgio Cantelli-Forti | Patrizia Hrelia
[1] V. Rotter,et al. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. , 1990, Oncogene.
[2] J. Bertino. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man. , 1973, Arthritis and rheumatism.
[3] S. Hecht,et al. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. , 2005, Cancer research.
[4] L. Gamet-Payrastre. Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. , 2006, Current cancer drug targets.
[5] L. Hu,et al. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. , 1997, International journal of radiation oncology, biology, physics.
[6] Jinsong Liu,et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.
[7] Y. Gazitt,et al. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. , 1994, Cancer research.
[8] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[9] P. Shastry,et al. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. , 2004, Neoplasia.
[10] S. Nair,et al. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. , 2006, Carcinogenesis.
[11] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[12] T. Kensler,et al. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Hrelia,et al. Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non-transformed cells. , 2004, Biochemical pharmacology.
[14] C. Rao,et al. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. , 2000, Carcinogenesis.
[15] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[16] J. Finley,et al. Cruciferous Vegetables: Cancer Protective Mechanisms of Glucosinolate Hydrolysis Products and Selenium , 2004, Integrative cancer therapies.
[17] P. Hrelia,et al. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. , 2002, Carcinogenesis.
[18] T. Kensler,et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.